HIPCARE trial to assess effectiveness and cost of a care-package for managing hip fractures in older adults

HIPCARE: A cluster randomised controlled trial with embedded process evaluation to investigate the clinical and cost effectiveness of multidisciplinary care in the management of patients with a fracture of the hip - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090066

Enrollment

9000

Registered

2025-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S789- Traumatic amputation of hip and thigh, level unspecified

Interventions

Intervention1: HIPCARE INTERVENTION package: Intervention HIPCARE INTERVENTION package Hospitals in the intervention group will receive support on how to improve the current care pathway for hip fra

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 60 years or over, having surgery for a hip fracture.

Exclusion criteria

Exclusion criteria: The participant will not enter the study if they, or a carer are unlikely to be available for follow-up at 120 days, e.g. foreign national returning to another country.

Design outcomes

Primary

Measure	Time frame
Health-related quality of life (by EuroQol EQ-5D-5L13 index) at 120 days post-surgery.Timepoint: Health-related quality of life (by EuroQol EQ-5D-5L13 index) at 120 days post-surgery.	—

Secondary

Measure	Time frame
Comparison of complication rate within the first 120 days post-surgery, using Medical records and bespoke participant questionnaireTimepoint: 120 days post-surgery;Comparison of healthcare and broader resource implications within the first 120 days post-surgery.Timepoint: Baseline, 120 days post-surgery ;Estimation of cost-effectiveness of the trial treatmentsTimepoint: 120 days post-surgery;Comparison of mortality between the treatment groups in the first 120 days post-surgeryTimepoint: 120 days post-surgery;Comparison of mobility between the treatment groups at 120 days post-surgery, using Modified New Mobility ScoreTimepoint: Baseline, 120 days post-surgery ;Comparison of the proportion of participants who have returned to their pre-fracture residential status by 120 days post-surgery, using Bespoke Residential Status questionnaireTimepoint: Baseline, 120 days post-surgery	—

Measure

Time frame

Comparison of complication rate within the first 120 days post-surgery, using Medical records and bespoke participant questionnaireTimepoint: 120 days post-surgery;Comparison of healthcare and broader resource implications within the first 120 days post-surgery.Timepoint: Baseline, 120 days post-surgery ;Estimation of cost-effectiveness of the trial treatmentsTimepoint: 120 days post-surgery;Comparison of mortality between the treatment groups in the first 120 days post-surgeryTimepoint: 120 days post-surgery;Comparison of mobility between the treatment groups at 120 days post-surgery, using Modified New Mobility ScoreTimepoint: Baseline, 120 days post-surgery ;Comparison of the proportion of participants who have returned to their pre-fracture residential status by 120 days post-surgery, using Bespoke Residential Status questionnaireTimepoint: Baseline, 120 days post-surgery

—

Countries

India, Nepal, Philippines, Thailand, Viet Nam

Contacts

Public ContactMs Deepti Beri

The George Institute for Global Health, India

jjagnoor1@georgeinstitute.org.in114158809193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026